Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...
BioTechniques4d
CRISPR for cancer: targeting cancer-specific genes in solid tumors
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
mRNA Vaccines Market Trends and Competition Analysis 2025-2030: Revenues are Projected to Nearly Double, Growing by ~$8 Billion
The "mRNA Vaccines Market by Technology Type, Route of Administration, Manufacturing Process, Vaccine Classification, Application Areas, End-User, Distribution Channel - Global Forecast 2025-2030" ...
AZoNano6d
Reprogramming Liver Immunity: A Lipid Nanoparticle Approach for Pancreatic Cancer Therapy
A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...
High Content Screening Market Is Expected To Progress At A CAGR Of 6.1% To Reach US$ 3,570.0 Million By 2034
The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.
CRISPR cuts gene from head and neck cancers through direct injection—50% of tumors eliminated in animal models
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...
GEN - Genetic Engineering and Biotechnology News12d
In Vivo Base Editing Gets Boost with Positive Initial Data Announced by Beam Therapeutics
Beam Therapeutics announced positive initial data for BEAM-302 in the Phase I/II trial in Alpha-1 Antitrypsin Deficiency (AATD).
Fierce Biotech12d
Daiichi taps Nosis to deliver RNA therapies beyond the liver
Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...
The American Bazaar13d
Deepak Nagrath gets Michigan university’s Departmental Faculty Award
Indian American professor recognized for his research program investigating cancer cell metabolism and his national ...
PharmiWeb13d
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock had risen 20.12% to HK$60.6, bringing the company ...
Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges
Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...